Bietamiverine (INN)
Bietamiverine (INN) is listed in Annex II as a prohibited substance for cosmetic products placed on the EU market.
Chemical identity and properties

2-(Diethylamino)ethyl alpha-phenyl-1-piperidineacetate
Bietamiverine is an alpha-amino acid ester. — ChEBI
- IUPAC name
- 2-(diethylamino)ethyl 2-phenyl-2-piperidin-1-ylacetate
- Molecular formula
- C19H30N2O2
- Molecular weight
- 318.5 g/mol
- Exact mass
- 318.230728204 Da
- XLogP3
- 3.5
- Topological polar surface area
- 32.8 Ų
- Hydrogen-bond donors
- 0
- Hydrogen-bond acceptors
- 4
- Covalent units
- 1
- Defined stereocentres
- 0
Also known as
16 more reported names
External database identifiers
- ChEBI:CHEBI:135362
- ChEMBL:CHEMBL2110892
- EPA DTXSID:DTXSID20861993
Retrieved from NIH PubChem on 2026-08-31 by checksum-valid CAS matching. Chemical properties do not replace the regulatory decision on this page.
Record details
Chemical name
Bietamiverine (INN)
Chemical / IUPAC name
1-Piperidineacetic acid, alpha-phenyl-, 2-(diethylamino)ethyl ester
Regulatory information
Key data
Related records for Bietamiverine (INN)
Direct matches are limited for this record, so nearby entries from Annex II are shown as well.
Azacyclonol (INN) and its salts
Butopiprine (INN) and its salts
Pipradrol (INN) and its salts
alpha-Piperidin-2-ylbenzyl acetate, laevorotatory threoform (levofacetoperane (INN)) and its salts
Prunus laurocerasus L. ("cherry laurel water")
Physostigma venenosum Balf.
Radioactive substances, as defined by Directive 96/29/Euratom (1) laying down the basic safety stan…
What Annex II means for Bietamiverine (INN)
Bietamiverine (INN) is listed as a prohibited substance under Annex II of EU Cosmetics Regulation 1223/2009 and must not be intentionally added. Article 17 separately addresses unintended small quantities that are technically unavoidable under good manufacturing practice and compatible with the Article 3 safety requirement.
Formulators must screen their ingredients and raw materials to ensure none contain this substance. Suppliers should provide documentation confirming absence when requested.
The page also surfaces 12 related annex records with overlapping identifiers, annex logic or naming patterns.
Compliance checklist
- Verify this substance is absent from all raw materials and finished formulations.
- Request absence confirmation or CoA from raw material suppliers.
- Document the screening result in the Product Information File (PIF).
Frequently asked questions
Source note for Annex II record Bietamiverine (INN)
This page summarizes one Annex II record for Bietamiverine (INN) from public European Commission cosmetic materials and adds linked inventory or identifier matches when available.
Use this record page to review Annex II conditions for Bietamiverine (INN), but confirm any final regulatory decision against the current official annex wording and source files.
Tools & next steps
Check your formula
Paste a full INCI list to detect Bietamiverine (INN) and other flagged EU annex records in one pass.
INCI CheckerCompare entries
Compare Bietamiverine (INN) side by side with another annex record to review differences in restrictions, concentrations and annex placement.
CompareBrowse the annex
See all records in Annex II and compare regulatory conditions across substances in this annex.
Open Annex II